Shenzhen Neptunus Bioengineering Co Ltd Cash Flow Conversion Efficiency
Shenzhen Neptunus Bioengineering Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shenzhen Neptunus Bioengineering Co Ltd (000078) has a cash flow conversion efficiency ratio of -0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-16.37 Million ≈ $-2.40 Million USD) by net assets (CN¥2.85 Billion ≈ $416.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shenzhen Neptunus Bioengineering Co Ltd (1998–2025)
Cash flow conversion efficiency of Shenzhen Neptunus Bioengineering Co Ltd from 1998 to 2025. This chart illustrates how Shenzhen Neptunus Bioengineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 000078 stock price for real-time trading data and today's change.
Shenzhen Neptunus Bioengineering Co Ltd Cash Flow Conversion Ratio Explained
Shenzhen Neptunus Bioengineering Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shenzhen Neptunus Bioengineering Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shenzhen Neptunus Bioengineering Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Shenzhen Neptunus Bioengineering Co Ltd worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Keystone Realtors Limited
NSE:RUSTOMJEE
|
-0.075x |
|
First Foundation Inc.
NYSE:FFWM
|
-0.027x |
|
Irish Residential Properties
IR:IRES
|
0.019x |
|
Caisse Regionale de Credit Agricole Mutuel de Normandie Seine SC
PA:CCN
|
0.003x |
|
Wolong Real Estate Group Co Ltd
SHG:600173
|
0.016x |
|
Mastek Limited
NSE:MASTEK
|
0.047x |
|
Shandong Haihua Co Ltd
SHE:000822
|
0.007x |
|
Shanghai Zhenhua Heavy Industries Co Ltd B
SHG:900947
|
0.126x |
Annual Cash Flow Conversion Efficiency for Shenzhen Neptunus Bioengineering Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Shenzhen Neptunus Bioengineering Co Ltd from 1998 to 2025. Review 000078 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.18 Billion ≈ $318.49 Million |
CN¥104.39 Million ≈ $15.28 Million |
0.048x | +244.96% |
| 2024-12-31 | CN¥2.84 Billion ≈ $416.13 Million |
CN¥39.54 Million ≈ $5.79 Million |
0.014x | +114.30% |
| 2023-12-31 | CN¥4.22 Billion ≈ $617.14 Million |
CN¥-410.19 Million ≈ $-60.02 Million |
-0.097x | -823.85% |
| 2022-12-31 | CN¥6.11 Billion ≈ $894.15 Million |
CN¥-64.33 Million ≈ $-9.41 Million |
-0.011x | -108.88% |
| 2021-12-31 | CN¥7.31 Billion ≈ $1.07 Billion |
CN¥866.12 Million ≈ $126.74 Million |
0.119x | -46.22% |
| 2020-12-31 | CN¥7.49 Billion ≈ $1.10 Billion |
CN¥1.65 Billion ≈ $241.53 Million |
0.220x | -23.74% |
| 2019-12-31 | CN¥7.85 Billion ≈ $1.15 Billion |
CN¥2.27 Billion ≈ $331.97 Million |
0.289x | +282.22% |
| 2018-12-31 | CN¥7.16 Billion ≈ $1.05 Billion |
CN¥-1.14 Billion ≈ $-166.11 Million |
-0.159x | +57.83% |
| 2017-12-31 | CN¥6.47 Billion ≈ $946.76 Million |
CN¥-2.43 Billion ≈ $-356.01 Million |
-0.376x | -47.65% |
| 2016-12-31 | CN¥5.88 Billion ≈ $860.13 Million |
CN¥-1.50 Billion ≈ $-219.06 Million |
-0.255x | -703.04% |
| 2015-12-31 | CN¥2.14 Billion ≈ $313.60 Million |
CN¥90.51 Million ≈ $13.24 Million |
0.042x | +164.08% |
| 2014-12-31 | CN¥1.78 Billion ≈ $260.85 Million |
CN¥-117.48 Million ≈ $-17.19 Million |
-0.066x | -1.10% |
| 2013-12-31 | CN¥1.89 Billion ≈ $276.27 Million |
CN¥-123.07 Million ≈ $-18.01 Million |
-0.065x | +15.69% |
| 2012-12-31 | CN¥1.06 Billion ≈ $154.67 Million |
CN¥-81.73 Million ≈ $-11.96 Million |
-0.077x | +60.55% |
| 2011-12-31 | CN¥971.04 Million ≈ $142.09 Million |
CN¥-190.33 Million ≈ $-27.85 Million |
-0.196x | -531.98% |
| 2010-12-31 | CN¥902.62 Million ≈ $132.08 Million |
CN¥40.96 Million ≈ $5.99 Million |
0.045x | -84.77% |
| 2009-12-31 | CN¥692.59 Million ≈ $101.35 Million |
CN¥206.34 Million ≈ $30.19 Million |
0.298x | +13.26% |
| 2008-12-31 | CN¥780.79 Million ≈ $114.25 Million |
CN¥205.39 Million ≈ $30.05 Million |
0.263x | +369.89% |
| 2007-12-31 | CN¥903.62 Million ≈ $132.23 Million |
CN¥50.59 Million ≈ $7.40 Million |
0.056x | -10.00% |
| 2006-12-31 | CN¥868.76 Million ≈ $127.13 Million |
CN¥54.04 Million ≈ $7.91 Million |
0.062x | +39.82% |
| 2005-12-31 | CN¥805.26 Million ≈ $117.83 Million |
CN¥35.82 Million ≈ $5.24 Million |
0.044x | +205.31% |
| 2004-12-31 | CN¥1.45 Billion ≈ $212.47 Million |
CN¥-61.34 Million ≈ $-8.98 Million |
-0.042x | -114.41% |
| 2003-12-31 | CN¥1.44 Billion ≈ $211.22 Million |
CN¥-28.44 Million ≈ $-4.16 Million |
-0.020x | +63.65% |
| 2002-12-31 | CN¥2.06 Billion ≈ $301.91 Million |
CN¥-111.83 Million ≈ $-16.36 Million |
-0.054x | -29.21% |
| 2001-12-31 | CN¥1.97 Billion ≈ $288.97 Million |
CN¥-82.84 Million ≈ $-12.12 Million |
-0.042x | +90.83% |
| 2000-12-31 | CN¥238.75 Million ≈ $34.94 Million |
CN¥-109.25 Million ≈ $-15.99 Million |
-0.458x | -367.67% |
| 1999-12-31 | CN¥205.69 Million ≈ $30.10 Million |
CN¥-20.13 Million ≈ $-2.95 Million |
-0.098x | +54.56% |
| 1998-12-31 | CN¥177.08 Million ≈ $25.91 Million |
CN¥-38.13 Million ≈ $-5.58 Million |
-0.215x | -- |
About Shenzhen Neptunus Bioengineering Co Ltd
Shenzhen Neptunus Bioengineering Co., Ltd. engages in the research and development, manufacturing, and distribution of pharmaceuticals in China. The company also provides distribution of medical devices, and other medical supplies, as well as related value-added services. It serves medical institutions, drug retailers, and distributors. Shenzhen Neptunus Bioengineering Co., Ltd. was founded in 19… Read more